Antitumor activity of the combination of artemisinin and epirubicin in human leukemia cells.

Margarita Y ZhelyazkovaNadya G Hristova-AvakumovaGeorgi Tsv Momekov

Published in: Folia medica (2022)

This study presents a new opportunity to enhance the effectiveness of epirubicin-based treatment regimens with addition of artemisinins for resistant tumors.

Keyphrases

induced apoptosis
endothelial cells
randomized controlled trial
cell cycle arrest
bone marrow
cell death
pluripotent stem cells
combination therapy